Research / ZS / Fundamental state Inspectable configuration
State dimensions Filing 0001713683-21-000238 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
402.15% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 0th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.80% · OPTIONAL · VALID
Operating cash generation 92th Own-history percentile · N=13
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
40.46% · OPTIONAL · VALID
Revenue growth 100th Own-history percentile · N=10
Evidence method Yoy · gp.fundamentals.revenue
61.68% · CORE · VALID
Gross margin 0th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.gross_margin
77.37% · CORE · VALID
Operating margin 7th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.operating_margin
-32.26% · CORE · VALID
R&D intensity 100th Own-history percentile · N=14
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
28.29% · OPTIONAL · VALID
SBC intensity 86th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
39.00% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Oct 31, 2021 7/8 normalized Level 3 Jan 31, 2022 5/6 normalized Level 3 Apr 30, 2022 7/8 normalized Level 3 Jul 31, 2022 8/8 normalized Level 3 Oct 31, 2022 8/8 normalized Level 3 Jan 31, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 31, 2023 8/8 normalized Level 3 Oct 31, 2023 8/8 normalized Level 3 Jan 31, 2024 6/6 normalized Level 3 Apr 30, 2024 8/8 normalized Level 3 Jul 31, 2024 8/8 normalized Level 3 Oct 31, 2024 8/8 normalized Level 3 Jan 31, 2025 8/8 normalized Level 3 Apr 30, 2025 8/8 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 135.72%
Current 402.15%
Delta 266.42% Capex Intensity Decreased
Previous 7.16%
Current 2.80%
Delta -4.36% Cash Generation Increased
Previous 30.02%
Current 40.46%
Delta 10.45% Growth Increased
Previous 56.07%
Current 61.68%
Delta 5.60% Margin Decreased
Previous 77.67%
Current 77.37%
Delta -0.30% Profitability Decreased
Previous -30.87%
Current -32.26%
Delta -1.39% R And D Intensity Increased
Previous 25.95%
Current 28.29%
Delta 2.34% Sbc Intensity Increased
Previous 38.41%
Current 39.00%
Delta 0.59% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.